Related Experiment Videos

Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats

H W Pfister1, U Koedel, S Lorenzl

  • 1Department of Neurology, University of Munich, FRG.

Stroke
|December 1, 1992
PubMed
Abstract

Insights

Pneumococcal cell wall components trigger harmful changes in brain blood flow, pressure, and water content during meningitis. Antioxidants like superoxide dismutase and deferoxamine help mitigate these early-stage effects.

Area of Science:

  • Neuroscience
  • Pathophysiology
  • Pharmacology

Background:

  • Pneumococcal meningitis involves complex pathophysiological changes.
  • Cell wall components of Streptococcus pneumoniae are implicated in meningitis progression.

Purpose of the Study:

  • To investigate if pneumococcal cell wall components alter cerebral blood flow, brain water content, and intracranial pressure.
  • To determine if antioxidants can modulate these early-phase meningitis alterations.

Main Methods:

  • Rats were challenged intracisternally with pneumococcal cell wall components or controls.
  • Regional cerebral blood flow, intracranial pressure, and brain water content were measured.
  • Antioxidants (superoxide dismutase, deferoxamine) were administered to assess their modulatory effects.

Main Results:

  • Pneumococcal cell wall components significantly increased cerebral blood flow, intracranial pressure, and brain water content.
  • Superoxide dismutase and deferoxamine administration attenuated these increases.
  • Polyethylene glycol-conjugated superoxide dismutase alone showed a minor increase in cerebral blood flow, attributed to the carrier.

Conclusions:

  • Pneumococcal cell wall components, including teichoic acid, induce significant pathophysiological changes in experimental meningitis.
  • Oxygen radicals play a crucial role in these early-stage alterations.
  • Antioxidant therapies show potential in managing early-phase pneumococcal meningitis.

Related Concept Videos